Testing a slower way of giving radiation for diffuse midline glioma
Original title: A Phase-1 Trial to Investigate the Use of Pulsed Low-dose Rate Radiotherapy in Diffuse Midline Gliomas.
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early safety test to find a dose that people can handle.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests a different way of giving radiation to see how well people handle it.
Who this trial is for. This trial is for people with a brain tumor called diffuse midline glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary. Most of them are children. It tests pulsed low-dose-rate radiation, which gives the radiation in a different way.
Where it stands. The trial is measuring how well people tolerate this kind of radiation. It is also trying to find a dose that is safe to use in later studies. The trial has not reported results yet.
What this means, and what it doesn't
What it could mean: Doctors want to know if this way of giving radiation is easier on the body. Someone who fits this group could ask their care team about it. The care team can explain if it makes sense for them.
What it doesn't mean: This does not mean the treatment works. A trial is a test, not a proven treatment. Joining one is not a guarantee that it will help you. It is not a promise of a cure.
Source: ClinicalTrials.gov, November 5, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.